NDC 76420-918 – Sennosides and Docusate Sodium
Sennosides 8.6 mg/1; Docusate Sodium 50 mg/1 · Tablet · Oral
Product NDC76420-918
Product details
- Brand name
- Sennosides and Docusate Sodium
- Generic name
- Sennosides, Docusate Sodium
- Labeler
- Asclemed USA, Inc.
- Dosage form
- Tablet
- Route
- Oral
- Marketing category
- OTC MONOGRAPH DRUG · M007
- Marketed since
- August 1, 2020
- Listing expires
- December 31, 2026
Active ingredients
- Sennosides 8.6 mg/1
- Docusate Sodium 50 mg/1
Uses, dosage, side effects and warnings for Sennosides and Docusate Sodium →
Package NDC codes (4)
| Package NDC | Description | Since |
|---|---|---|
| 76420-918-01 | 100 TABLET in 1 BOTTLE (76420-918-01) | Feb 8, 2025 |
| 76420-918-30 | 30 TABLET in 1 BOTTLE (76420-918-30) | Feb 8, 2025 |
| 76420-918-60 | 60 TABLET in 1 BOTTLE (76420-918-60) | Feb 8, 2025 |
| 76420-918-90 | 90 TABLET in 1 BOTTLE (76420-918-90) | Feb 8, 2025 |
Other Sennosides and Docusate Sodium products
- 60687-622 Sennosides 8.6 mg/1; Docusate Sodium 50 mg/1 · Tablet · American Health Packaging
- 55154-2578 Sennosides 8.6 mg/1; Docusate Sodium 50 mg/1 · Tablet · Cardinal Health 107, LLC
- 14803-301 Docusate Sodium 50 mg/1; Senna Alata Leaf 8.6 mg/1 · Tablet · Elysium Pharmaceuticals Ltd
- 69618-065 Sennosides 8.6 mg/1; Docusate Sodium 50 mg/1 · Tablet · Reliable-1 Laboratories LLC
- 49483-097 Sennosides 8.6 mg/1; Docusate Sodium 50 mg/1 · Tablet, Film Coated · TIME CAP LABORATORIES, INC